Laboratory of Drug Addiction Pharmacology, Department of Pharmacology, Institute of Pharmacology, Polish Academy of Sciences, Smętna 12, PL 31-343 Kraków, Poland.
Pharmacol Rep. 2010 Nov-Dec;62(6):1005-14. doi: 10.1016/s1734-1140(10)70362-5.
The endogenous brain serotonin (5-HT) system is believed to have an important modulatory influence in mediating drug reward and seeking mechanisms. Data from preclinical behavioral studies have provided emerging evidence that 5-HT(6) receptors, among other 5-HT receptors, may play a significant role in the mechanisms of action of psychostimulant addicted drugs. The aim of the present study was to investigate whether the selective pharmacological blockade or activation of 5-HT(6) receptors altered the maintenance of cocaine self-administration, reinstatement of cocaine-seeking behavior following an extinction of cocaine self-administration or cocaine-evoked conditioned place preference in rats. We also evaluated the effects of 5-chloro-N-(4-methoxy-3-piperazin-1-ylphenyl)-3-methyl)-2-benzothiophene-sulfonamide (SB 271046, a 5-HT(6) receptor antagonist) or N-1-(6-chloroimidazo-[2,1-b]-[1,3]thiazole-5-sulfonyl)tryptamine (WAY 181187, a potent 5-HT(6) receptor agonist) on locomotor activity in rats. Our results indicate that SB 271046 (1-10 mg/kg) altered cocaine-maintained self-administration as well as cocaine-evoked reinstatement of cocaine seeking and expression of cocaine place preference in rats.We also demonstrate that pharmacological stimulation of 5-HT(6) receptors by WAY 181187 (3-30 mg/kg) attenuated the expression of cocaine conditioned place preference but not cocaine self-administration and reinstatement of cocaine seeking. WAY 181187 at the highest dose used (30 mg/kg) reduced basal locomotor activity. Despite current results, the precise function and therapeutic relevance of 5-HT(6) receptors need further clarification.
内源性脑 5-羟色胺(5-HT)系统被认为对调节药物奖赏和寻求机制具有重要的调制作用。来自临床前行为研究的数据提供了新的证据,表明 5-HT(6)受体,以及其他 5-HT 受体,可能在成瘾药物的作用机制中发挥重要作用。本研究的目的是研究选择性药理学阻断或激活 5-HT(6)受体是否会改变可卡因自我给药的维持、可卡因自我给药消退后可卡因寻求行为的复燃或可卡因诱发的条件性位置偏好。我们还评估了 5-氯-N-(4-甲氧基-3-哌嗪-1-基苯基)-3-甲基-2-苯并噻吩磺酰胺(SB 271046,5-HT(6)受体拮抗剂)或 N-1-(6-氯咪唑并-[2,1-b]-[1,3]噻唑-5-磺酰基)色胺(WAY 181187,一种有效的 5-HT(6)受体激动剂)对大鼠运动活动的影响。我们的结果表明,SB 271046(1-10mg/kg)改变了可卡因维持的自我给药以及可卡因诱发的可卡因寻求的复燃和可卡因位置偏好的表达。我们还表明,WAY 181187(3-30mg/kg)对 5-HT(6)受体的药理学刺激减弱了可卡因条件性位置偏好的表达,但不影响可卡因自我给药和可卡因寻求的复燃。WAY 181187 在使用的最高剂量(30mg/kg)时降低了基础运动活动。尽管目前的结果表明,5-HT(6)受体的确切功能和治疗相关性仍需进一步阐明。